Articles Tagged With:
-
Baloxavir Marboxil (Xofluza)
Baloxavir marboxil is a novel, oral, antiviral agent approved by the Food and Drug Administration (FDA) on Oct. 24, 2018, for the treatment of acute uncomplicated influenza in patients 12 years of age and older.
-
Staphylococcus aureus on the Playground and in the Gym — Is It Inescapable?
Staphylococcus aureus, including methicillin-resistant S. aureus, is a frequent surface environmental contaminant on both children’s playgrounds and in adult fitness centers.
-
Adenovirus and CNS Disease in Children
Forty-eight immunocompetent children with adenovirus-associated central nervous system disease were described. Thirty-eight percent of patients died or experienced permanent neurologic sequelae.
-
Sleep Tight, Don’t Let the Mucorales Bite
Mucorales were found to commonly contaminate linen delivered to 15 transplant and cancer centers in the United States.
-
The Slippery Slope of Inappropriate Antibiotic Use in Children
Inappropriate antibiotic use for a child with a viral respiratory infection is not a “one and done” error. Children who receive antibiotics when diagnosed with a viral respiratory infection are more likely to seek care for viral infections subsequently and to receive inappropriate antibiotics again.
-
Probiotics Do Not Prevent C. difficile Infection in Hospitalized Patients
A retrospective cohort study from a single California hospital found the administration of probiotics to patients receiving antibiotics did not reduce the incidence of healthcare facility-onset Clostridioides difficile infection.
-
EPs, Hospitals Face Liability for ED Nurse Practitioners’ Negligence
If an ED nurse practitioner is sued for malpractice, the hospital will “almost always” be named, says one attorney. However, the hospital may not rally behind the care given by the nurse defendant. For this reason, nurse practitioners should carry their own malpractice insurance.
-
Vague Symptoms Trigger Sepsis Care Delays and Lawsuits
More than one-third of ED patients with septic shock reported only vague symptoms at presentation, according to the authors of a recent study of septic shock patients discharged from a large urban ED. These patients had delayed antibiotic administration and were at a higher risk of mortality compared to patients with explicit infection symptoms. Another recent analysis revealed that a faster completion of a three-hour bundle of sepsis care and quick administration of antibiotics — but not rapid completion of an initial bolus of IV fluids — were associated with lower risk-adjusted, in-hospital mortality rates.
-
High Policy Limits Make EP a ‘Deep Pocket’ for Plaintiff
One insider recommends emergency physicians spend money ensuring their assets are protected from third parties rather than on "higher premiums for larger limits."
-
Was ED Unprepared for Critically Ill Child? Guidelines Could Help Prove It
The risk of a poor outcome for a critically ill child is high when a system is not ready to meet the emergency needs of that child. New guidelines from the National Pediatric Readiness Project can be used to prove that an ED fell short in this regard.